PALMS study finds dual-biomarker test to be highly sensitive and specific for cervical precancersContinue reading
Category Archives: BioScience
FDA Approves First Breakthrough Therapy – Genentech’s Gazyva(TM)
FDA Approves Gazyva™ (Obinutuzumab) for People With Previously Untreated Chronic Lymphocytic Leukemia (CLL)Continue reading
TGen-Scottsdale Healthcare research shows ability to do whole genome and whole transcriptome sequencing for patients with advanced cancers
Faster analysis of genetic variations should uncover new drug targets and pathways even as cancers mutate beyond initial therapiesContinue reading
Absence of the SMG1 protein could contribute to Parkinson’s and other neurological disorders
TGen-led study links lack of SMG1 to protein aggregates associated with Parkinson’s disease, forms of dementia and multiple systems atrophy (MSA)Continue reading
UA College of Medicine – Phoenix, SynDaver Strike Formal Collaboration
Simulation Technology Improves Medical Education, Creates JobsContinue reading
VisionGate Presents Clinical Data At IASLC Meeting Showing Its Cell-CT™ 3D Imaging Platform Detects Lung Cancer With High Sensitivity And Specificity
SYDNEY and PHOENIX, Oct. 28, 2013 — VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT™, can detect lung cancer in sputum samples with high sensitivity and specificity. The data was presented at the International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer.Continue reading
UA President Outlines The Basics Of The GME Crisis and Offers A Solution
Ann Weaver Hart, President of the University of Arizona outlines the basics of the GME Crisis and offers a solution
Pancreatic cancer patient survival is ‘significantly higher’ with nab-paclitaxel, in study led by TGen and Scottsdale Healthcare
NEJM today publishes findings of international trial resulting in recent FDA approval of Abraxane (nab-paclitaxel) for patients with advanced pancreatic cancer.Continue reading
Regenesis expects sale or final private round next year, CEO says
Regenesis Biomedical profiled in BioPharm Insight…
Continue reading